Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Plx Pharma Inc (PLXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,133
  • Shares Outstanding, K 8,752
  • Annual Sales, $ 750 K
  • Annual Income, $ 900 K
  • 60-Month Beta 5.33
  • Price/Sales 63.93
  • Price/Cash Flow N/A
  • Price/Book 7.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.33
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.37
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +17.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.00 +9.99%
on 03/25/19
6.21 -11.41%
on 03/21/19
-0.44 (-7.42%)
since 03/18/19
3-Month
4.06 +35.46%
on 02/15/19
6.44 -14.60%
on 02/11/19
+0.62 (+12.69%)
since 01/18/19
52-Week
1.00 +449.95%
on 12/27/18
6.44 -14.60%
on 02/11/19
+1.65 (+42.84%)
since 04/18/18

Most Recent Stories

More News
PLx Pharma Inc. to Discuss 2018 Fourth Quarter and Full Year Financial Results on March 8, 2019 Conference Call

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore(TM) 325 mg and Vazalore(TM) 81...

PLXP : 5.50 (unch)
PLx Pharma Inc. Announces Adjournment of Special Meeting of Stockholders

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore(TM) 325 mg and Vazalore(TM) 81...

PLXP : 5.50 (unch)
Shirley Family Office Sends Letter to PLx Pharma (PLXP) Board of Directors

--Intends to Vote AGAINST the Proposed CPS Financing

PLXP : 5.50 (unch)
PLx Pharma Inc. to Present at Biotech Showcase 2019

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore(TM) 325 mg and Vazalore(TM) 81...

PLXP : 5.50 (unch)
PLx Pharma Inc. Reports First Quarter 2018 Results

PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec(TM) 325 mg and Aspertec(TM) 81 mg...

PLXP : 5.50 (unch)
Blog Exposure - Arcturus Initiates Lawsuit against Former CEO Joseph Payne for Misconduct and Violations of Federal Disclosure

Stock Monitor: PLx Pharma Post Earnings Reporting

PLXP : 5.50 (unch)
ARCT : 7.50 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade PLXP with:

Business Summary

PLx Pharma Inc. is a specialty pharmaceutical company. It focused on developing clinically validated and patent-protected PLxGuard(TM) delivery system to provide safe and effective aspirin products. PLx Pharma Inc., formerly known as Dipexium Pharmaceuticals Inc., is based in NEW YORK, United States....

See More

Key Turning Points

2nd Resistance Point 5.56
1st Resistance Point 5.53
Last Price 5.50
1st Support Level 5.44
2nd Support Level 5.38

See More

52-Week High 6.44
Last Price 5.50
Fibonacci 61.8% 4.36
Fibonacci 50% 3.72
Fibonacci 38.2% 3.08
52-Week Low 1.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar